Accès ouvert
2025
article
OpenAlex
Aejin Lee, Silvia de Lamo Castelli, Patrick Sellers, Sagarika Taneja et autres
Therapies for type 2 diabetes primarily target hyperglycemia; however, complications are also triggered by advanced glycation end products (AGEs). We hypothesize that the anti-diabetic efficacy of insulin-like growth factor-binding protein 4 (IGFBP4) is enhanced when it assembles with a specific amino acid …
us, kr, es
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Zhijie Deng, Aejin Lee, Tao Lin, Sagarika Taneja et autres
Diabetes is a major risk factor for Alzheimer’s disease (AD). Amino acid compound 2 (AAC2) improves glycemic and cognitive functions in diabetic mouse models through mechanisms distinct from insulin. Our goal was to compare the effects of AAC2, insulin, and their nanofiber-forming …
us, kr
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Aejin Lee, McKensie L. Mason, Tao Lin, Shashi Bhushan Kumar et autres
Diabetes poses a high risk for debilitating complications in neural tissues, regulating glucose uptake through insulin-dependent and predominantly insulin-independent pathways. Supramolecular nanostructures provide a flexible strategy for combinatorial regulation of glycemia. Here, we compare the effects of free insulin to insulin bound …
us
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Aejin Lee, Yuan Sun, Tao Lin, No‐Joon Song et autres
us
(code pays fourni par la source)
Accès ouvert
2018
article
OpenAlex
Rumana Yasmeen, Qiwen Shen, Aejin Lee, Jacob H. Leung et autres
Adipokine leptin regulates neuroendocrine circuits that control energy expenditure, thermogenesis and weight loss. However, canonic regulators of leptin secretion, such as insulin and malonyl CoA, do not support these processes. We hypothesize that epiregulin (EREG), a growth factor that is secreted from …
us, cn, in
(code pays fourni par la source)